Vinay K. Jain

10 Patents

• US125347642026

  Crenolanib for Treating FLT3 Mutated Proliferative Disorders Associated Mutations

  Arog Pharmaceuticals, Inc.

  0 cites
• US124045552025

  Crenolanib for Treating FLT3 Mutated Proliferative Disorders Associated Mutations

  Arog Pharmaceuticals, Inc.

  0 cites
• US123835492025

  Combination Therapy of Crenolanib and Apoptosis Pathway Agents for the Treatment of Proliferative Disorders

  Arog Pharmaceuticals, Inc.

  0 cites
• US122959482025

  Crenolanib for Treating FLT3 Mutated Proliferative Disorders Relapsed/refractory to Prior Treatment

  Arog Pharmaceuticals, Inc.

  0 cites
• US121717572024

  Crenolanib for Treating FLT3 Mutated Proliferative Disorders

  Arog Pharmaceuticals, Inc.

  0 cites
• US119694202024

  Combination Therapy of Crenolanib and Apoptosis Pathway Agents for the Treatment of Proliferative Disorders

  AROG PHARMACEUTICALS, Inc.

  0 cites
• US118575462024

  Crenolanib for Treating FLT3 Mutated Proliferative Disorders Relapsed/refractory to Prior Treatment

  AROG PHARMACEUTICALS, Inc.

  0 cites
• US117380172023

  Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase

  Arog Pharmaceuticals, Inc.

  0 cites
• US116423402023

  Method of Inhibiting Mutant C-KIT

  AROG PHARMACEUTICALS, Inc.

  0 cites
• US116025332023

  Crenolanib Combination Therapy

  Arog Pharmaceuticals, Inc.

  0 cites